title: Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal.
authors.affiliation: Department of Surgery, Kantonspital Olten, Switzerland.
authors.forename: Rachel
authors.initials: R
authors.lastname: Rosenthal
authors.forename: Carsten T
authors.initials: CT
authors.lastname: Viehl
authors.forename: Ulrich
authors.initials: U
authors.lastname: Guller
authors.forename: Walter P
authors.initials: WP
authors.lastname: Weber
authors.forename: Michel
authors.initials: M
authors.lastname: Adamina
authors.forename: Giulio C
authors.initials: GC
authors.lastname: Spagnoli
authors.forename: Michael
authors.initials: M
authors.lastname: Heberer
authors.forename: Markus
authors.initials: M
authors.lastname: Zuber
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000276:immunology; D017326:Clinical Trials, Phase III as Topic; D003606:Dacarbazine / Q000627:therapeutic use; D003713:Dendritic Cells / Q000276:immunology; D000939:Epitopes / Q000276:immunology; D005732:Gangliosides / Q000276:immunology; D016233:Immunotherapy, Active / Q000379:methods*; D007372:Interferons / Q000627:therapeutic use; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D014616:Vaccinia virus / Q000276:immunology
chemical_list: D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D019496:Cancer Vaccines; D000939:Epitopes; D005732:Gangliosides; D003606:Dacarbazine; D007372:Interferons